The limitations of the present study are as follows: a retrospective nature, the inability to obtain information about whether stillborn babies have chromosomal abnormalities, unavailability of records of hemoglobin values at the beginning and throughout the pregnancy to compare live births and stillbirths outcomes, and the inability to obtain sufficient data on anemia management such as erythropoietin therapy. This evidence concerns the gene EPO and anemia (phenotype).